Advertisement

Breast Cancer Research and Treatment

, Volume 39, Issue 2, pp 239–240 | Cite as

Endoglin/CD 105 may not be an optimal tumor endothelial treatment target

  • Arjan W. Griffioen
  • Cora A. Damen
  • Geert H. Blijham
  • Gerard Groenewegen
Letter to the editor

Keywords

Public Health Treatment Target Optimal Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Thorpe PE, Burrows FJ: Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 36: 237–231, 1995PubMedGoogle Scholar
  2. 2.
    Griffioen AW, Damen C, Martinotti S, Blijham GH, Groenewegen G: Endothelial ICAM-1 expression is suppressed in human malignancies: role of angiogenic factors. Cancer Res, in pressGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Arjan W. Griffioen
    • 1
  • Cora A. Damen
    • 1
  • Geert H. Blijham
    • 1
  • Gerard Groenewegen
    • 1
  1. 1.Dept. of Internal Medicine and Medical Oncology, Laboratory for Angiogenesis Research, F.02.126University Hospital UtrechtUtrechtThe Netherlands

Personalised recommendations